Showing results (2421-2430 of 2,531) with videos related to
Sort By:
Pageof 254
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Sex-Specific Clinical Outcomes After Treatment of Left Main Coronary Artery Disease. A NOBLE SubstudyMargaret B McEntegart, Niels R Holm, Martin M Lindsay, et al.Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.The Annals of Thoracic Surgery|April 20, 2023
Food Deserts Increase Readmission After Esophagectomy for Cancer: A Multi-institutional StudyJoseph D Phillips, Kayla A Fay, Elliot Wakeam, et al.Plos One|September 7, 2012
Prioritizing key resilience indicators to support coral reef management in a changing climateTim R McClanahan, Simon D Donner, Jeffrey A Maynard, et al.Ecology|January 23, 2025
Seagrass wasting disease prevalence and lesion area increase with invertebrate grazing across the northeastern PacificLillian R Aoki, Carmen J Ritter, Deanna S Beatty, et al.Journal of Virology|December 1, 1996
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitorJ H Condra, D J Holder, W A Schleif, et al.Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.Lancet (London, England)|April 5, 2026
Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trialEmil Nielsen Holck, Niels R Holm, David Hildick-Smith, et al.Genome Research|July 7, 2005
Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general populationKhalid K Alharbi, Mohammed A Aldahmesh, Emmanuel Spanakis, et al.Pageof 254